MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%

ACON — Aclarion, Inc. Common Stock

Nasdaq

Aclarion, Inc. Common Stock

Back to Screener
$2.44
+0.03(+1.24%)
O
2.45
H
2.50
L
2.43
V
7.1K
⏱️ End-of-day dataAs of Oct 1, 2026

Chart

About ACON

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

IndustrySERVICES-MEDICAL LABORATORIES
SectorNot available
IPO DateApr 22, 2022
Employees11
Stock ExchangeNasdaq
Ticker SymbolACON

Key Financial Statistics

Market Cap$7.47M
P/E RatioN/A
Dividend YieldN/A
EPSN/A
BetaN/A
52-Week Range$1.95 - $586,116.00
52-Week Avg Volume79.8K
VWAP$2.46
Transactions156
Total Recorded Bars1,115 days